bismuth subsalicylate 262 MG Chewable Tablet [Pepto-bismol]
RxNorm concept 211151, branded drug (sbd). Prescribable name: Pepto-Bismol 262 MG Chewable Tablet.
- RxCUI
- 211151
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/211151 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Pepto-Bismol InstaCool 262 MG Chewable Tablet; Pepto-Bismol To-Go 262 MG Chewable Tablet; Pepto-bismol 262 MG Chewable Tablet
Related concepts
- bismuth subsalicylate 262 MG (SCDC, consists of)
- bismuth subsalicylate 262 MG [Pepto-bismol] (SBDC, consists of)
- Chewable Tablet (DF, has dose form)
- Pepto-bismol (BN, has ingredient)
- bismuth subsalicylate 262 MG Chewable Tablet (SCD, tradename of)
Linked data
NDCs
- 00149000010
- 00149000017
- 00149003977
- 00149032040
- 00149032642
- 00149033690
- 01490000281
- 01490003977
- 01490003978
- 01490003979
- 01490003980
- 01490032642
- 01490039770
- 01490039780
- 01490039790
- 01490326420
- 30149000185
- 37000001612
- 37000001624
- 37000001804
- 37000047709
- 37000047710
- 37000047712
- 37000069130
- 37000099624
- 37000099672
- 50090055300
- 58933000212
- 58933001102
- 58933001104
- 58933001112
- 58933001130
- 58933001148
- 58933001190
- 66715642302
- 66715652302
- 66715972302
- 66715972303
- 67751015501
- 67751015502
- 67751015506
- 69423083124
- 69423083224
- 69423096324
- 69423096348
- 69423096372
- 84126032170
- 85237190300
- 85237190301
- 85237190302
- 85237190307
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 211151 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/211151 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 211151. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.